Cell Impact AB Statistics

Total Valuation

Cell Impact AB has a market cap or net worth of SEK 55.28 million. The enterprise value is 65.81 million.

Market Cap	55.28M
Enterprise Value	65.81M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Cell Impact AB has 696.27 million shares outstanding. The number of shares has increased by 463.84% in one year.

Current Share Class	n/a
Shares Outstanding	696.27M
Shares Change (YoY)	+463.84%
Shares Change (QoQ)	+17.50%
Owned by Insiders (%)	8.30%
Owned by Institutions (%)	22.62%
Float	638.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.46
PB Ratio	0.25
P/TBV Ratio	0.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.66
EV / Sales	1.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.88

Financial Position

The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.14.

Current Ratio	3.03
Quick Ratio	1.07
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	-0.41
Interest Coverage	-38.62

Financial Efficiency

Return on equity (ROE) is -38.45% and return on invested capital (ROIC) is -20.76%.

Return on Equity (ROE)	-38.45%
Return on Assets (ROA)	-19.24%
Return on Invested Capital (ROIC)	-20.76%
Return on Capital Employed (ROCE)	-41.75%
Revenue Per Employee	924,951
Profits Per Employee	-2.45M
Employee Count	41
Asset Turnover	0.12
Inventory Turnover	0.61

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.06% in the last 52 weeks. The beta is 1.65, so Cell Impact AB's price volatility has been higher than the market average.

Beta (5Y)	1.65
52-Week Price Change	-50.06%
50-Day Moving Average	0.09
200-Day Moving Average	0.17
Relative Strength Index (RSI)	43.20
Average Volume (20 Days)	1,925,236

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cell Impact AB had revenue of SEK 37.92 million and -100.43 million in losses. Loss per share was -0.16.

Revenue	37.92M
Gross Profit	6.01M
Operating Income	-99.02M
Pretax Income	-100.35M
Net Income	-100.43M
EBITDA	-80.16M
EBIT	-99.02M
Loss Per Share	-0.16

Full Income Statement

Balance Sheet

The company has 20.39 million in cash and 30.92 million in debt, giving a net cash position of -10.53 million or -0.02 per share.

Cash & Cash Equivalents	20.39M
Total Debt	30.92M
Net Cash	-10.53M
Net Cash Per Share	-0.02
Equity (Book Value)	219.08M
Book Value Per Share	0.31
Working Capital	48.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -62.23 million and capital expenditures -12.40 million, giving a free cash flow of -74.64 million.

Operating Cash Flow	-62.23M
Capital Expenditures	-12.40M
Free Cash Flow	-74.64M
FCF Per Share	-0.11

Full Cash Flow Statement

Margins

Gross margin is 15.86%, with operating and profit margins of -261.11% and -264.83%.

Gross Margin	15.86%
Operating Margin	-261.11%
Pretax Margin	-264.61%
Profit Margin	-264.83%
EBITDA Margin	-211.37%
EBIT Margin	-261.11%
FCF Margin	n/a

Dividends & Yields

Cell Impact AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-463.84%
Shareholder Yield	-463.84%
Earnings Yield	-181.67%
FCF Yield	-135.01%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cell Impact AB has an Altman Z-Score of -2.22. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.22
Piotroski F-Score	n/a